2019 International Congress » Epidemiology

Date: Wednesday, September 25, 2019

Time: 1:15pm-2:45pm

Location: Les Muses, Level 3

Meeting: 2019 International Congress

1:15pm-2:45pm: A Registry for Parkinson’s Disease in Utah

P. Moretti, A. Nakashima, M. Zorn, S. Woltz, L. Farese, L. Cannon-Albright, S. Pulst (Salt Lake City, UT, USA)

1:15pm-2:45pm: Advanced Stage of Parkinson’s Disease: From Identification to Characterization and Disease Burden Assessment Using a Nationwide Database

Y. Barer, T. Gurevich, G. Chodick, N. Giladi, R. Gross, R. Cohen, L. Bergmann, Y. Jalundhwala, V. Shalev, A. Thaler (Tel Aviv-Yafo, Israel)

1:15pm-2:45pm: Analysis of the role of known susceptibility genes of Parkinson’s disease in cancer

P-E. Sugier, M. Law, M. Iles, M. Meta-Analysis Consortium, M. Kvaskoff, T. Truong, A. Elbaz (Saint-Aubin, France)

1:15pm-2:45pm: Annual Incidence of Parkinson’s Disease in Mexico: A Report of National Public Health Institutions

E. Velazquez-Avila, D. Martinez-Ramirez, A. Banegas-Lagos, A. Cervantes-Arriaga, K. Salinas-Barbosa, S. Isais-Millan, M. Rodriguez-Violante (Monterrey, Mexico)

1:15pm-2:45pm: Antibiotic exposure and Risk for Parkinson’s Disease

T. Mertsalmi, E. Pekkonen, F. Scheperjans (Helsinki, Finland)

1:15pm-2:45pm: Antipsychotics Use in Parkinson’s Disease and Mortality Risks

WM. Liu, JH. Wang, HY. Chen, R. Lo (Hualien, Taiwan)

1:15pm-2:45pm: Association between Parkinson disease and the risk of cardiovascular disease and all-cause mortality: A nationwide, register-based cohort study

DH. Kim, DY. Kwon, MH. Park, KW. Park (Ansan City, Republic of Korea)

1:15pm-2:45pm: Association of active and passive smoking with Parkinson’s disease in women: the E3N cohort study

M. Canonico, F. Artaud, D. Cerasuolo, I. Degaey, P. Gerbouin-Rerolle, A. Kowal, E. Roze, G. Severi, MC. Boutron-Ruault, A. Elbaz (Villejuif, France)

1:15pm-2:45pm: Association of metallic air pollution with Parkinson’s disease: a French nationwide incidence study

T. Vlaar, E. Lequy-Flahault, E. Moutengou, C. Meyer, S. Leblond, A. Elbaz, F. Moisan (Villejuif, France)

1:15pm-2:45pm: Associations of gait disorders and future falls in the elderly: a prospective population-based study

K. Marini, P. Mahlknecht, O. Schorr, M. Baumgartner, A. Djamshidian, A. Gasperi, S. Kiechl, G. Rungger, H. Stockner, J. Willeit, W. Poewe, K. Seppi (Innsbruck, Austria)

1:15pm-2:45pm: Can Safinamide Help to Stabilize Dopaminergic Treatment in Parkinson’s Disease?

B. Solano Vila, A. Cots Foraster, M. Montserrat Roses (Girona, Spain)

1:15pm-2:45pm: Clinical and epidemiological data on Parkinson’s disease in older adults: experience of a single Italian centre.

T. Schirinzi, G. Di Lazzaro, M. Pierantozzi, A. Stefani, N. Mercuri, A. Pisani (Rome, Italy)

1:15pm-2:45pm: Clinical profile of idiopathic Parkinson’s disease in patients admitted to Mohamed VI University Hospital center of Marrakech

A. Boudanga, N. Jalami, M. Chraa, N. Kissani (Marrakech, Morocco)

1:15pm-2:45pm: Clostridium Difficile Infection and Risk of Parkinson’s Disease: A Swedish Population-Based Cohort Study

X. Kang, A. Ploner, J. Ludvigsson, D. Williams, N. Pedersen, K. Wirdefeldt (Solna, Sweden)

1:15pm-2:45pm: Comparison of Dementia Patients With and Without Parkinson’s Disease Before Dementia-related Psychosis Occurs: An Administrative Claims Data Analysis

A. Shim, B. Skoog, V. Abler, N. Rashid, R. Halpern, E. Koep, M. Frazer (San Diego, CA, USA)

1:15pm-2:45pm: Development of a Predictive Model for Progressive Supranuclear Palsy Using Real World Data

E. Viscidi, Y. Zabar, T. Dam, M. Juneja, J. Kupferman, V. Kupelian, S. Eaton, I. Litvan, G. Hoglinger (Cambridge, MA, USA)

1:15pm-2:45pm: Establishing the first apomorphine treatment registry in Thailand: prospective data collection to inform optimal care of Parkinson’s disease patients

R. Bhidayasiri, O. Phokaewvarangkul, K. Boonpang, T. Boonmongkol, Y. Thongchuam, N. Kantachadvanich, J. Sringean, P. Panyakaew, P. Jagota (Bangkok, Thailand)

1:15pm-2:45pm: Expenditures on pesticides and incidence of Parkinson’s disease in French farmers: a nationwide study

L. Perrin, J. Spinosi, L. Chaperon, S. Kab, F. Moisan, A. Elbaz (Villejuif Cedex, France)

1:15pm-2:45pm: Frequency and pattern of movement disorders in a Neurologic clinic in North Central Nigeria: a 3- year review

E. Iwuozo, R. Obiako (Makurdi, Nigeria)

1:15pm-2:45pm: Frequency of Cardiovascular Abnormalities in Mexican Patients with Early Parkinson´s Disease

JA. Juárez, M. Violante, A. Arriaga, A. González, A. Salas, L. Vidal, R. Vicioso, C. Roa, I. López, M. Soto (Mexico, Mexico)

1:15pm-2:45pm: Gamma-glutamyltransferase and the risk of Parkinson’s disease: A National Health Service big data analysis

D. Yoo, R. Kim, E. Jung, K. Han, C. Shin, J. Lee (Seoul, Republic of Korea)

1:15pm-2:45pm: Gender differences for Motor and non motor symptoms in Parkinson’s Disease among Pakistani population

S. Naureen, A. Arshad, N. Ahmad (Islamabad, Pakistan)

1:15pm-2:45pm: Gender-dependent improvement in the survival of Parkinson’s disease patients in Finland

T. Kuusimäki, S. Kurki, J. Sipilä, H. Salminen-Mankonen, O. Carpén, V. Kaasinen (Turku, Finland)

1:15pm-2:45pm: Inflammatory Conditions in Parkinson’s Disease

B. Krishnamachari, S. Shermon, M. Goldfinger, A. Leder, B. Harper, J. Donoghue (Old Westbury, NY, USA)

1:15pm-2:45pm: Knowledge, Attitude and Practices about Movement Disorders in India

B. Shetty, S. Mittal, P. Kukkle (Bangalore, India)

1:15pm-2:45pm: LATE ONSET OF PARKINSON’S DISEASE

I. Smolentseva, N. Amosova, A. Kuzmina (Moscow, Russian Federation)

1:15pm-2:45pm: Life expectancy with and without Parkinson’s disease in the general population

L. Dommershuijsen, A.. Ikram, K. Ikram (Rotterdam, Netherlands)

1:15pm-2:45pm: Long-term Yearly Trends of Feeding Tube Placement in Neurodegenerative Disorders

D. Kim, R. Jones, A. D'Abreu, J. Friedman, U. Akbar (Providence, RI, USA)

1:15pm-2:45pm: Longitudinal analysis of the relation between trajectories of dopaminergic agonists use and BMI in Parkinson’s disease

F. Artaud, PC. Lee, M. Vidailhet, JC. Corvol, A. Elbaz (Saint-Aubin, France)

1:15pm-2:45pm: Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain

K. Methawasin, R. Suppawat, P. Petborom, M. Wongwandee, S. Rungruanghiranya, T. Asawavichienjinda (Ongkharak, Thailand)

1:15pm-2:45pm: Movement disorders in neurologic consultation of Marrakesh University Hospital

L. Berrhoute, J. El Mesbahy, N. Kissani (Marrakesh, Morocco)

1:15pm-2:45pm: Movement Disorders Spectrum in a Private Practice setup in India : A 7 Year Study

P. Kukkle (Bangalore, India)

1:15pm-2:45pm: New epidemiological data of Parkinson’s Disease in Ukraine

Y. Trufanov, N. Svyrydova, A. Galusha, V. Svistun, I. Harkava, H. Bondarenko, N. Zhhilova (Kyiv, Ukraine)

1:15pm-2:45pm: NS-PARK cohort: a nationwide real life longitudinal cohort of PD patients

H. Alfaisal, F. Durif, S. Thobois, L. Defebvre, JP. Azulay, P. Couratier, P. Damier, D. Devos, S. Drapier, A. Doe Demaindreville, S. Frismand, C. Geny, C. Giordana, JL. Houeto, P. Krystkowiak, E. Magnin, D. Maltête, W. Meissner, C. Moreau, E. Moro, P. Remy, C. Thiriez, C. Tranchant, F. Viallet, M. Vidailhet, E. Dellapina, V. Chaigneau, C. Dongmo, F. Tubach, Y. de Rycke, O. Rascol, JC. Corvol (Paris, France)

1:15pm-2:45pm: Number of people with Parkinson’s dementia in New Zealand

T. Pitcher, D. Myall, J. Dalrymple-Alford, M. Macaskill, T. Anderson (Christchurch, New Zealand)

1:15pm-2:45pm: Parkinsonism in a movement disorder reference center in El Salvador

D. Pereira (San Salvador, El Salvador)

1:15pm-2:45pm: Patterns of Lewy body dementia diagnosis and treatment in Florida

M. Armstrong, R. Eisinger, C. Garvan, B. Patel (Gainesville, FL, USA)

1:15pm-2:45pm: Prevalence and clinical characteristics of Parkinson Disease in Chernivtsi Region of Ukraine

O. Yaremchuk, I. Yaremchuk (Chernivtsi, Ukraine)

1:15pm-2:45pm: Prevalence of advanced Parkinson’s Disease in patients treated in the hospitals of the Spanish public health care system: PARADISE Study (interim analysis)

JC. Martínez-Castrillo, P. Martínez-Martín, A. Burgos, G. Arroyo, N. García, MR. Luquín, JM. Arbelo (Las Palmas, Spain)

1:15pm-2:45pm: Prevalence of Parkinson’s disease in a district of central highlands of Peru: Preliminary report

E. Sarapura-Castro, K. Milla-Neyra, S. Montano, I. Mata, M. Inca-Martinez, J. Rios-Pinto, C. Cosentino, P. Mazzetti, M. Cornejo-Olivas (Lima, Peru)

1:15pm-2:45pm: Prevalence of Parkinsonian Syndrom in the World

MRS. Sabirova (Tashkent, Uzbekistan)

1:15pm-2:45pm: Retrospective analysis of hospitalized Parkinson ‘s disease patients from 2002 to 2014 in Suzhou district

C. Mao, J. Chen, H. Gu, D. Chen, J. Huang, J. Chen, Y. Wang, W. Luo, C. Liu (Changshu, China)

1:15pm-2:45pm: Self-reported demographic, genetic, symptom, and treatment data of subjects in the Fox Trial Finder

M. Bailey, A. Gera, Y. Liu, B. Ouyang, G. Pal (Chicago, IL, USA)

1:15pm-2:45pm: Sick leaves in the years preceding the diagnosis of Parkinson’s disease: a nationwide case-control study in France

F. Moisan, L. Mandereau-Bruno, E. Moutengou, L. Carcaillon-Bentata, A. Elbaz (Saint-Maurice, France)

1:15pm-2:45pm: Spatial distribution of Parkinson’s disease in the Canton of Geneva, Switzerland

V. Fleury, R. Himsl, S. Joost, N. Nicastro, I. Guessous, P. Burkhard (Lausanne, Switzerland)

1:15pm-2:45pm: Study of Epidemiological Risk Factors in a Male-Only North Indian Parkinson’s Cohort

K. Shukla, N. Sawal (Chandigarh, India)

1:15pm-2:45pm: The Economic Burden of Parkinson’s Disease (PD) in the United States

C. Tanner, R. Albin, N. Dahodwala, R. Dorsey, W. Yang, L. Schmiel, I. Cintina, C. Kopil, J. Beck, J. Hamilton (San Francisco, CA, USA)

1:15pm-2:45pm: The Nigeria Parkinson Disease Registry

O. Ojo, S. Abubakar, K. Wahab, O. Olugbo, E. Nwazor, O. Oshinaike, A. Bello, U. Williams, O. Ekenze, N. Okubadejo, NPD. Collaborators (Idi-Araba, Nigeria)

1:15pm-2:45pm: The proportion of patients with early-onset Parkinson’s disease: a systematic review and meta-analysis

G. Nepal (Kathmandu, Nepal)

1:15pm-2:45pm: Translation, validation, diagnostic accuracy and reliability of a Parkinson´s disease screening questionnaire in three countries in Africa: A progress report and preliminary data

NU. Okubadejo, A. Shalash, J. Doumbe, C. Tanner, R. Walker, C. Dotchin, OP. Agabi, E. Hamid, A. Helmi, H. Elrassas, T. Rushdi, O. Ojo, O. Oguntunde, S. Calvo, L. Aguado, E. Cubo (Burgos, Spain)

1:15pm-2:45pm: Use of e-PROMs in Parkinson’s disease clinics: A qualitative study of healthcare professionals perceptions

A. Khardali, L. Hughes, E. Lane (Cardiff, United Kingdom)

1:15pm-2:45pm: Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson’s disease

F. Hopfner, M. Wod, G. Höglinger, M. Blaabjerg, T. Roesler, G. Kuhlenbäumer, K. Christensen, G. Deuschl, A. Pottegård (Kiel, Germany)

1:15pm-2:45pm: Wilson’s disease in Finland

J. Sipilä, M. Hietala, V. Kaasinen (Joensuu, Finland)

« View all sessions from the 2019 International Congress.